Clinical trials
Recruiting Observational Immune System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 6 |
| IRCCS San Raffaele | 3 |
| Imagine Institute | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| National Institute of Dental and Craniofacial Research (NIDCR) | 1 |
| Sir Mortimer B. Davis - Jewish General Hospital | 1 |
| University Hospital, Brest | 1 |
| University Hospital, Toulouse | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immune System Diseases | 21 |
| Autoimmune Diseases | 5 |
| Primary Immunodeficiency Diseases | 4 |
| Immunologic Deficiency Syndromes | 3 |
| Neoplasms | 3 |
| Nervous System Diseases | 3 |
| Rheumatic Diseases | 3 |
| Asthma | 2 |
| Eosinophilia | 2 |
| Genetic Diseases, Inborn | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.